Isabel Chu

2.3k citations

12 papers · 1.8k indexed · 1 hit paper · h-index 11

Impact in

Oncology top 2%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
Cancer Research top 5%

Papers in ⓘ

Oncology 6
- Cancer-related Molecular Pathways 3
- Cancer Cells and Metastasis 2
- HER2/EGFR in Cancer Research 1
Cell Biology 3
- Cellular Mechanics and Interactions 2
- Microtubule and mitosis dynamics 2

Co-authors: Joyce M. Slingerland (4 shared papers)Ludger Hengst (2 shared papers)Kimberly Blackwell (1 shared paper)Susie Chen (1 shared paper)Jun Sun (2 shared papers)Angel Arnaout (2 shared papers)Jeffrey E. Green (3 shared papers)Lara H. El Touny (2 shared papers)
Journals: Cancer Research (2 papers)Nature reviews. Cancer (1 paper)Scientific Reports (1 paper)Journal of Proteome Research (1 paper)Science Advances (1 paper)
Partner nations: United States Canada Austria

In The Last Decade

Isabel Chu

12 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy 2008 · 797 citations

Peers

Countries citing papers authored by Isabel Chu

Since Specialization

Citations

This map shows the geographic impact of Isabel Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Chu more than expected).

Fields of papers citing papers by Isabel Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Chu. The network helps show where Isabel Chu may publish in the future.

Co-authors

The 25 scholars most cited alongside Isabel Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Isabel Chu Line = papers co-authored together Isabel Chu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work
1	The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy Nature reviews. Cancer ·Isabel Chu, Ludger Hengst, Joyce M. Slingerland Hit paper breakdown →	2008	797
2	Metastatic Growth from Dormant Cells Induced by a Col-I–Enriched Fibrotic Environment Cancer Research ·Dalit Barkan, Lara H. El Touny, Aleksandra M. Michalowski, Jane Ann Smith, Isabel Chu, A. Sally Davis, Joshua D. Webster, Shelley Hoover, R. Mark Simpson, Jack Gauldie, Jeffrey E. Green	2010	308
3	p27 Phosphorylation by Src Regulates Inhibition of Cyclin E-Cdk2 Cell ·Isabel Chu, Jun Sun, Angel Arnaout, Harriette Kahn, Wedad Hanna, Steven A. Narod, Ping Sun, Cheng‐Keat Tan, Ludger Hengst, Joyce M. Slingerland	2007	292
4	The Dual ErbB1/ErbB2 Inhibitor, Lapatinib (GW572016), Cooperates with Tamoxifen to Inhibit Both Cell Proliferation- and Estrogen-Dependent Gene Expression in Antiestrogen-Resistant Breast Cancer Cancer Research ·Isabel Chu, Kimberly Blackwell, Susie Chen, Joyce M. Slingerland	2005	161
5	BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases Oncogene ·Mark J. Hoenerhoff, Isabel Chu, Daniel Barkan, Z. Liu, Sonal Datta, Goberdhan P. Dimri, J E Green	2009	86
6	Src promotes estrogen-dependent estrogen receptor α proteolysis in human breast cancer Journal of Clinical Investigation ·Isabel Chu, Angel Arnaout, Sophie Loiseau, Jun Sun, Arun Seth, Chris McMahon, Kathy Chun, Bryan T. Hennessy, Gordon B. Mills, Zafar Nawaz, Joyce M. Slingerland	2007	72
7	Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential Scientific Reports ·Jason Lohmueller, Shuji Sato, Lana Popova, Isabel Chu, Meghan Tucker, Roberto Barberena, Gregory Innocenti, Mare Čudić, James Dongjoo Ham, Wan Cheung Cheung, Roberto D. Polakiewicz, Olivera J. Finn	2016	32
8	Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer Breast Cancer Research ·Christina N. Bennett, Christine C. Tomlinson, Aleksandra M. Michalowski, Isabel Chu, Dror Luger, Lara Mittereder, Olga Aprelikova, James Shou, Helen Piwinica-Worms, Natasha J. Caplen, Melinda G. Hollingshead, Jeffrey E. Green	2012	26
9	Expression of GATA3 in MDA-MB-231 Triple-negative Breast Cancer Cells Induces a Growth Inhibitory Response to TGFß PLoS ONE ·Isabel Chu, W. Victoria Lai, Olga Aprelikova, Lara H. El Touny, Hosein Kouros‐Mehr, Jeffrey E. Green	2013	25
10	Comparison of Strong Cation Exchange and SDS-PAGE Fractionation for Analysis of Multiprotein Complexes Journal of Proteome Research ·Sudipto Das, Allen D. Bosley, Xiaoying Ye, King C. Chan, Isabel Chu, Jeffery E. Green, Haleem J. Issaq, Timothy D. Veenstra, Þorkell Andrésson	2010	19
11	Kinase-dead PKB gene therapy combined with hyperthermia for human breast cancer Cancer Gene Therapy ·Nancy Ma, Paul E. Szmitko, Anthony Brade, Isabel Chu, Alex Lo, James R. Woodgett, Henry J. Klamut, Fei‐Fei Liu	2003	13
12	Synthetic dysmobility screen unveils an integrated STK40-YAP-MAPK system driving cell migration Science Advances ·Ling-Yea Yu, Ting-Jen Tseng, Hsuan-Chao Lin, Chi-Lin Hsu, Ting-Xuan Lu, C. Y. Tsai, Yu-Chiao Lin, Isabel Chu, Chien-Tzu Peng, Hou-Jen Chen, Feng‐Chiao Tsai	2021	3

About Isabel Chu

Isabel Chu is a scholar working on Oncology, Cell Biology, Cancer Research, Molecular Biology and Genetics, having authored 12 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Hedgehog Signaling Pathway Studies (2 papers), Cancer Cells and Metastasis (2 papers), RNA modifications and cancer (2 papers), Estrogen and related hormone effects (2 papers), Cellular Mechanics and Interactions (2 papers), Microtubule and mitosis dynamics (2 papers) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Oncology (1.0k citations), Cancer Research (346 citations), Molecular Biology (1.1k citations), Cell Biology (267 citations) and Immunology and Allergy (68 citations). Isabel Chu has collaborated with scholars based in United States, Canada and Austria. Frequent co-authors include Joyce M. Slingerland, Ludger Hengst, Kimberly Blackwell, Susie Chen, Jun Sun, Angel Arnaout, Jeffrey E. Green, Lara H. El Touny, Aleksandra M. Michalowski and Cheng‐Keat Tan. Their work appears in journals such as Cancer Research, Nature reviews. Cancer, Scientific Reports, Journal of Proteome Research and Science Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact